The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.
The study, designed to compare flexitarians with vegans and omnivores, focused on young and middle-aged adults in good health who had been following the same diet for at least one full year.
The 67-year-old cardiologist was accused of inappropriately touching multiple female patients. All charges were cleared except a single assault charge for hugging one patient and kissing her on the cheek without consent.
The panel's decision will be based on data from the TRILUMINATE study, which was ultimately positive for Abbott, but did lead to certain questions about patient outcomes.
Many patients do not want to limit their salt intake, even when a doctor tells them the numerous health benefits. Salt substitutes may represent another way forward.
The rise of TAVR as a go-to treatment option for many AS patients has been one of the biggest stories in cardiology for several years now. How will advanced AI models impact this trend going forward?
The late-breaking five-year results of the Evolut Low-Risk Trial presented at ACC.25 showed positive results for the Evolut TAVR system when compared to SAVR.
One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations.
Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.
